跳至主要内容
临床试验/ITMCTR2026001670
ITMCTR2026001670进行中(未招募)Unknown

Lingbao Huxin Dan for the primary prevention of coronary heart disease in high-risk populations: a field randomized controlled trial

Harbin Medical University Endemic Disease Center0 个研究点开始时间: 2026年8月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 至 75(—)
性别
All

入选标准

  • (1)Age range: 45 - 75 years old. Gender not restricted. (2)Individuals diagnosed with coronary heart disease at secondary-level or higher hospitals, including those with hypertension, diabetes, and high cholesterol; (3)Have signed the informed consent form and are willing to participate in this study.

排除标准

  • (1)Those with an expected lifespan of less than 2 years; (2)patients who experienced severe adverse events such as acute myocardial infarction or cerebral hemorrhage in the past 3 months;(3) patients with cardiovascular and cerebrovascular diseases such as coronary heart disease or stroke; (4)patients with malignant tumors; (5)pregnant women; (6)active infected individuals;(7) and other situations that the researchers consider unsuitable for participation in this study.

研究者

发起方
Harbin Medical University Endemic Disease Center

相似试验